| IntroductionIn recent years the investigation confirmed that the research of the traditional Chinese medicine to prevent and cure myocardial ischemia had gotten gratifying progress, the range of reach has already been from over-emphasize the research of single drug and its active ingredient to regard the the research of compound preparation as important. Nowadays, the cardiovascular disease has became the foe that threaten the health of human body, especially, the attack rate of CAD ( coronary artery disease) getting up every year, how to prevent and cure CAD effectively is one of the important destination of this research. The shuangxiangyou preparation extracted from the levant storax oil and the dalbergiae odoriferae oil has significant pharmacological action on the disease of cardiovascular system ,such as anti-myocardial ischemia,anti-platelet aggregation and an-ti-thrombogenesis, et cetera. To view from the angle of the long-term sense, the soft capsule of shuangxiangyou has extremely important clinic significance and fine development prospect. The view of this study is to ascertain the optimal proportion of the two Ingredients in Shuangxiangyou soft capsules, and to investigate the effect of Shuangxiangyou on myocardial ischemia of rats induced by Isoprel and on platelet aggregation in the whole animal experiment. |